Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.

Neisseria meningitidis is a major cause of bacterial meningitis worldwide, especially in the African meningitis belt, and has a high associated mortality. The meningococcal serogroups A, W, and X have been responsible for epidemics and almost all cases of meningococcal meningitis in the meningitis b...

Full description

Bibliographic Details
Main Authors: Micoli, F, Romano, MR, Tontini, M, Cappelletti, E, Gavini, M, Proietti, D, Rondini, S, Swennen, E, Santini, L, Filippini, S, Balocchi, C, Adamo, R, Pluschke, G, Norheim, G, Pollard, A, Saul, A, Rappuoli, R, MacLennan, C, Berti, F, Costantino, P
Format: Journal article
Language:English
Published: 2013

Similar Items

Similar Items